Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Traws Pharma, Inc. | 1,065,600 | reported | 26 Jul 2018 | tx 54+2,280,586−260,014 |
| Ocugen, Inc. | 112,205 | reported | 09 Jun 2023 | tx 26+520,631−76,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2023 | GRANT_AWARD | Ocugen, Inc. | 112,205 | 0.00 USD | deriv |
| 06 Oct 2022 | EXERCISE | Ocugen, Inc. | 4,500 | 0.51 USD | |
| 06 Oct 2022 | SALE | Ocugen, Inc. | 4,500 | 1.83 USD | |
| 06 Oct 2022 | EXERCISE | Ocugen, Inc. | 4,500 | 0.00 USD | deriv |
| 18 Jul 2022 | SALE | Ocugen, Inc. | 7,500 | 2.57 USD | |
| 18 Jul 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 18 Jul 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Ocugen, Inc. | 140,091 | 0.00 USD | deriv |
| 18 Apr 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 18 Apr 2022 | SALE | Ocugen, Inc. | 7,500 | 2.83 USD | |
| 18 Apr 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 18 Jan 2022 | SALE | Ocugen, Inc. | 7,500 | 4.07 USD | |
| 18 Jan 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 18 Jan 2022 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 16 Dec 2021 | GRANT_AWARD | Ocugen, Inc. | 16,335 | 0.00 USD | deriv |
| 18 Oct 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 18 Oct 2021 | SALE | Ocugen, Inc. | 7,500 | 8.13 USD | |
| 18 Oct 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 19 Jul 2021 | SALE | Ocugen, Inc. | 7,500 | 6.40 USD | |
| 19 Jul 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 19 Jul 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 19 Apr 2021 | SALE | Ocugen, Inc. | 7,500 | 5.33 USD | |
| 19 Apr 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.51 USD | |
| 19 Apr 2021 | EXERCISE | Ocugen, Inc. | 7,500 | 0.00 USD | deriv |
| 01 Jan 2021 | GRANT_AWARD | Ocugen, Inc. | 126,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 26 Apr 2017.